Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Rheumatism and rheumatic heart disease in the school environment].

Probleme de reumatologie·2014

Same author

[Early diagnosis of rheumatism].

Probleme de reumatologie·2014

Same author

[Functional disorders and lesions of the liver in rheumatic disease].

Probleme de reumatologie·2014

Same author

Serum zinc and copper in hyperlipoproteinemia.

Biological trace element research·2013

Same author

Electrocardiography and conventional radiology accuracy compared to echocardiography in evaluating left ventricular remodelling patterns in hypertensive patients.

Panminerva medica·2008

Same author

Myocardial function in patients with breast cancer after therapy with anthracyclines and chest irradiation.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2007

Search research articles

Related Experiment Video

Updated: Dec 28, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

Guancydine, a new hypotensive agent with complex action.

S T Hărăgus, G Uza, C Duncea

|January 1, 1977

Summary

Guancydine effectively lowers blood pressure in hypertensive patients for up to 7 hours. This antihypertensive drug also reduces platelet aggregation and activates fibrinolysis, potentially preventing atherosclerosis and thrombosis.

Area of Science:

Pharmacology
Cardiovascular Medicine

Background:

Arterial hypertension is a significant risk factor for atherosclerosis and thrombosis.
Novel therapeutic agents are needed to manage hypertension and its complications.

Purpose of the Study:

To evaluate the antihypertensive effects and potential prophylactic role of Guancydine.
To investigate the impact of Guancydine on angiotensin II response and related physiological parameters.

Main Methods:

Clinical study involving nine hypertensive patients.
Administration of single oral doses of Guancydine (500-750 mg).
Monitoring of blood pressure, response to angiotensin II, and urinary excretion of electrolytes and water.

Main Results:

More Related Videos

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors

Published on: April 27, 2017

A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products

A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products

Published on: September 9, 2016

Related Experiment Videos

Last Updated: Dec 28, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors

Published on: April 27, 2017

A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products

A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products

Published on: September 9, 2016

Guancydine lowered blood pressure in 8 out of 9 patients for approximately 6-7 hours.

No impairment of vasopressor response to angiotensin II was observed.

Reduced excretion of water, Na, K, and Ca; decreased platelet adhesiveness; and activated fibrinolysis were noted.

Increased venous blood oxygenation and mild side effects like headache and orthostatic hypotension were reported.

Conclusions:

Guancydine demonstrates significant antihypertensive effects.
Its influence on platelet aggregation and fibrinolysis suggests a potential role in preventing cardiovascular complications.
Guancydine appears to be a safe antihypertensive agent with potential prophylactic benefits.